AMBS Stock | News | Quote | Stock Forum | Saturday, January 18,

New Post Public Reply Private Reply Replies (0) Message Board

Jan 18, 2014 at 1:51 AM

$AMBS Amarantus Bioscience Holdings, Inc. AMBS Company Overview

Amarantus Bioscience Holdings, Inc. AMBS Current Price and Quotes
Last Price 0.095
Previous Close 0.0883 Open 0.0882
Daily Range 0.0962 - 0.0805 52wk Range 0.1199 - 0.027
Volume 18,266,582 Dividend N/A
Average Vol (3m) 5,211,361 Yield N/A

AMBS Stock Message Board http://investorshangout.com/search?q=AMBS&...mp;yt1=Go!

Last Updated: Saturday, January 18, 2014 01:51:15 AM

Amarantus Bioscience Holdings, Inc. AMBS
Company Information

c/o Janssen Labs @QB3
953 Indiana Street
San Francisco, CA

Website: http://www.amarantus.com
Phone: 408-737-2734
Email: gerald@amarantus.com
Find us on:

Amarantus Bioscience Holdings, Inc. AMBS
Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company is focused on developing unique products and proprietary technologies for the potential treatment and/or diagnosis of Parkinson's disease, Alzheimer's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as tr...

Amarantus Bioscience Holdings, Inc. AMBS
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001424812
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Nov 19, 2012
Incorporated In: NV, USA
Year of Inc. 2008
Employees 3 a/o Nov 19, 2012
Company Officers/Contacts

Gerald E. Commissiong CEO, President, COO
Marc E. Faerber CFO, Treasurer, Secretary
John W. Commissiong CSO
Company Directors

Mark Benedyk
Gerald E. Commissiong
John W. Commissiong
Robert L. Harris
David A. Lowe
Company Notes

Formerly=Amarantus Bioscience, Inc. until 4-2013
Formerly=Amarantus Biosciences, Inc. until 12-2012
Formerly=Jumpkicks, Inc. until 6-2011
Service Providers

Auditor/Accountant
Silberstein Ungar, PLLC
30600 Telegraph Rd.
Suite 2175
Bingham Farms, MI, 48025
United States

Legal Counsel
Sichenzia Ross Friedman Ference LLP
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
LHA Inc.
800 Third Ave.
New York, NY, 10022
United States

Amarantus Bioscience Holdings, Inc. AMBS
AMBS Security Details

Share Structure

Market Value1 $52,387,160 a/o Jan 17, 2014
Shares Outstanding 551,443,794 a/o Nov 13, 2013
Float Not Available
Authorized Shares 1,000,000,000 a/o Nov 14, 2012
Par Value 0.001
Shareholders

Shareholders of Record 64 a/o Apr 26, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Jun 14, 2011 Jun 06, 2011 Jun 13, 2011
Security Notes

Capital Change=shs increased by 25 for 1 split. Ex-date=06/14/2011. Rec date=06/06/2011. Pay date=06/13/2011.
Short Selling Data

Short Interest 503 (-93.16%)
Dec 31, 2013
Significant Failures to Deliver No
Transfer Agent(s)

VStock Transfer

Amarantus Bioscience Holdings, Inc. AMBS Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Oct 31, 2010
Total Revenue - 224 192 -
Cost of Revenue - - - -
Gross Profit - 224 192 -
Operating Expenses

Research and Development 584 1,178 490 -
Sales, General and Admin. 3,506 2,786 924 57
Non-Recurring Items - - - -
Other - - - 1
Operating Income (4,090) (3,740) (1,223) (59)
Income From Continuing Operations

Add'l Income/Expense Items 473 315 94 -
Earnings Before Interest and Tax (3,617) (3,425) (1,128) (59)
Interest Expense 1,518 1,015 79 -
Earnings Before Tax (5,136) (4,440) (1,208) (59)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,136) (4,440) (1,208) (59)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,136) (4,440) (1,208) (59)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,136) (4,440) (1,208) (59)

Amarantus Bioscience Holdings, Inc. AMBS Recent News

Jan 17, 2014 Amarantus BioScience "2014: Initiation of Eltoprazine Phase 2b and LymPro Commercialization"
Jan 15, 2014 Amarantus Founders Gerald and Dr. John Commissiong Selected as Black Money's "50 Most Important African-Americans in Technology"
Jan 14, 2014 Amarantus In-Licenses Levadopa-Induced Dyskinesia Phase 2b-Ready Eltoprazine From PGI Drug Discovery
Jan 9, 2014 Gerald Commissiong, CEO of Amarantus to Participate in Twitter Chat, "The Human Brain"
Jan 6, 2014 Amarantus BioScience CEO Publishes New Blog Entitled "Unlocking Shareholder Value as Milestones Approach: Uplisting in 2014&quot;
Jan 6, 2014 Amarantus to Present at Biotech and Healthcare Conferences During JP Morgan Week in San Francisco
Dec 18, 2013 Amarantus Licenses MANF-Related Wolfram's and Diabetes Therapeutic and Diagnostic Intellectual Property From University of Massachusetts Medical School
Dec 17, 2013 Amarantus and Brewer Sports Announce ONE MIND for Research at 2nd #C4CT Concussion Awareness Summit Prior to Super Bowl XLVIII at United Nations
Dec 3, 2013 Amarantus Obtains Exclusive Option to License University of Miami Bascom Palmer Eye Institute's Intellectual Property for the Treatment of Retinal Diseases Using MANF and CDNF
Nov 26, 2013 Amarantus BioScience to Present at the LD Micro Sixth Annual Conference on December 3, 2013

1
2
next >

AMBS Amarantus Bioscience Holdings, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=AMBS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/AMBS/quote
Stock Chart http://www.otcmarkets.com/stock/AMBS/chart
Company Info http://www.otcmarkets.com/stock/AMBS/company-info
Recent News http://www.otcmarkets.com/stock/AMBS/news
Financials http://www.otcmarkets.com/stock/AMBS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/AMBS/filings
Short Sales http://www.otcmarkets.com/stock/AMBS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/AMBS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/AMBS/research
Summary http://finance.yahoo.com/q?s=AMBS
Historical Prices http://finance.yahoo.com/q/hp?s=AMBS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=AMBS
Basic Chart http://finance.yahoo.com/q/bc?s=AMBS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AMBS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=AMBS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=AMBS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=AMBS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=AMBS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=AMBS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=AMBS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=AMBS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=AMBS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=AMBS
Balance Sheet http://finance.yahoo.com/q/bs?s=AMBS
Cash Flow http://finance.yahoo.com/q/cf?s=AMBS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/AMBS
Market Watch http://www.marketwatch.com/investing/stock/AMBS
Bloomberg http://www.bloomberg.com/quote/AMBS:US
Morningstar http://quotes.morningstar.com/stock/s?t=AMBS
Bussinessweek http://investing.businessweek.com/research/st...icker=AMBS
Barchart http://www.barchart.com/quotes/stocks/AMBS
OTC Short Report http://otcshortreport.com/index.php?index=AMBS
Investopedia http://www.investopedia.com/markets/stocks/AMBS/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Voter Events by Valley Community Healthcare Aim to Empower

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Innventure Faces Major Lawsuit Over Misleading Investors

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Masimo's smartSET™ Revolutionizes Patient Monitoring

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Hyliion Class Action Deadline Nears for Investors

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

LG OLED evo W6: UAE Roadshow Starts with a Bang

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

AEVEX Facing Class Action Deadline Amid Stock Turmoil

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...